Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.

Intra- and inter-tumour heterogeneity in mutation burden are also likely to be significant determinants of treatment response, and are not routinely considered in current binary ‘wild-type/mutant’ tumour classifications.

also in 993 other papers